These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7658589)

  • 1. Quantification of crystal growth of calcium oxalate in gel and its modification by urinary constituents in a new flow model of crystallization.
    Achilles W; Freitag R; Kiss B; Riedmiller H
    J Urol; 1995 Oct; 154(4):1552-6. PubMed ID: 7658589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro formation of "urinary stones": generation of spherulites of calcium phosphate in gel and overgrowth with calcium oxalate using a new flow model of crystallization.
    Achilles W; Jöckel U; Schaper A; Burk M; Riedmiller H
    Scanning Microsc; 1995 Jun; 9(2):577-85; discussion 585-6. PubMed ID: 8714750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
    Fleming DE; Van Riessen A; Chauvet MC; Grover PK; Hunter B; van Bronswijk W; Ryall RL
    J Bone Miner Res; 2003 Jul; 18(7):1282-91. PubMed ID: 12854839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate dihydrate crystal growth.
    Werness PG; Duckworth SC; Smith LH
    Invest Urol; 1979 Nov; 17(3):230-3. PubMed ID: 40922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium oxalate crystal growth in the presence of mucin.
    Akbarieh M; Tawashi R
    Scanning Microsc; 1991 Dec; 5(4):1019-26; discussion 1026-7. PubMed ID: 1822027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
    Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
    Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature.
    Thongboonkerd V; Semangoen T; Chutipongtanate S
    Clin Chim Acta; 2006 May; 367(1-2):120-31. PubMed ID: 16458875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemical structure of dicarboxylic acids and their capacity inhibiting of calcium oxalate crystal growth].
    Deng SP; Hu P; Ouyang JM
    Guang Pu Xue Yu Guang Pu Fen Xi; 2007 Oct; 27(10):1981-4. PubMed ID: 18306777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Architecture of mixed calcium oxalate dihydrate and monohydrate stones.
    Iwata H; Iio S; Nishio S; Takeuchi M
    Scanning Microsc; 1992 Mar; 6(1):231-7; discussion 237-8. PubMed ID: 1626242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK; Chow K; Rao PN; Kavanagh JP
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation.
    Rodgers A
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S351-4. PubMed ID: 10541262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.